Quarterly report pursuant to Section 13 or 15(d)

Business Acquisition (Tables)

v3.21.2
Business Acquisition (Tables)
6 Months Ended
Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed

Based on the preliminary valuation, the total consideration of $2.5 million has been allocated to assets acquired and liabilities assumed based on their respective fair values as follows (amount in thousands):

         
Clinical lab material   $ 180  
Lab equipment     112  
Definite-lived intangible asset     1,307  
Total assets acquired     1,599  
Liabilities assumed     -  
Net identifiable assets acquired     1,599  
Goodwill     901  
Total consideration   $ 2,500